Cited by 490Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

Surgical ablation of atrial fibrillation during mitral-valve surgery

Open access
Gillinov, A. Marc, Gelijns, Annetine C., Parides, Michael K., DeRose, Joseph J., Moskowitz, Alan J., Voisine, Pierre, Ailawadi, Gorav, Bouchard, Denis +23 more·2015·New England Journal of Medicine

Abstract

BACKGROUND: Among patients undergoing mitral-valve surgery, 30 to 50% present with atrial fibrillation, which is associated with reduced survival and increased risk of stroke. Surgical ablation of atrial fibrillation has been widely adopted, but evidence regarding its safety and effectiveness is limited. METHODS: We randomly assigned 260 patients with persistent or long-standing persistent atrial fibrillation who required mitral-valve surgery to undergo either surgical ablation (ablation group) or no ablation (control group) during the mitral-valve operation. Patients in the ablation group underwent further randomization to pulmonary-vein isolation or a biatrial maze procedure. All patients underwent closure of the left atrial appendage. The primary end point was freedom from atrial fibrillation at both 6 months and 12 months (as assessed by means of 3-day Holter monitoring). RESULTS: More patients in the ablation group than in the control group were free from atrial fibrillation at both 6 and 12 months (63.2% vs. 29.4%, P<0.001). There was no significant difference in the rate of freedom from atrial fibrillation between patients who underwent pulmonary-vein isolation and those who underwent the biatrial maze procedure (61.0% and 66.0%, respectively; P=0.60). One-year mortality was 6.8% in the ablation group and 8.7% in the control group (hazard ratio with ablation, 0.76; 95% confidence interval, 0.32 to 1.84; P=0.55). Ablation was associated with more implantations of a permanent pacemaker than was no ablation (21.5 vs. 8.1 per 100 patient-years, P=0.01). There were no significant between-group differences in major cardiac or cerebrovascular adverse events, overall serious adverse events, or hospital readmissions. CONCLUSIONS: The addition of atrial fibrillation ablation to mitral-valve surgery significantly increased the rate of freedom from atrial fibrillation at 1 year among patients with persistent or long-standing persistent atrial fibrillation, but the risk of implantation of a permanent pacemaker was also increased. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00903370.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1500528

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Cox maze procedure and other forms of atrial fibrillation surgery have mainly been used in patients undergoing other open heart surgical procedures.

    “The Cox maze procedure and other, often simpler, forms of AF surgery have mainly been used in patients undergoing other open heart surgical procedures.461,466,[784][785][786][787][788][789][790][791][792][793][794][795][796][797][798]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gillinov, A. M., Gelijns, A. C., Parides, M. K., DeRose, J. J., Moskowitz, A. J., Voisine, P., Ailawadi, G., Bouchard, D., Smith, P. K., Mack, M. J., Acker, M. A., Mullen, J. C., Rose, E. A., Chang, H. L., Puskas, J. D., Couderc, J.-P., Gardner, T. J., Varghese, R., Horvath, K. A., Bolling, S. F., Michler, R. E., Geller, N. L., Ascheim, D. D., Miller, M. A., Bagiella, E., Moquete, E. G., Williams, P., Taddei-Peters, W. C., O'Gara, P. T., Blackstone, E. H., & Argenziano, M.
Affiliations
  • Cleveland Clinic (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • University of Virginia Medical Center (US)
  • Montreal Heart Institute (CA)
  • Duke Medical Center (US)
  • University of Pennsylvania (US)
  • University of Alberta (CA)
  • Mount Sinai Health System (US)
  • University of Rochester Medicine (US)
  • Christiana Care Health System (US)
  • National Institutes of Health (US)
  • Michigan Medicine (US)
  • Albert Einstein College of Medicine (US)
  • National Heart, Lung, and Blood Institute (US)
  • Columbia University Irving Medical Center (US)
Venue
New England Journal of Medicine
Published
2015-04-09
Volume
372
Issue
15
Pages
1399-1409
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2108591114
Cited by
490
References
41
Citations by year
2026: 21 · 2025: 40 · 2024: 52 · 2023: 20 · 2022: 53 · 2021: 42 · 2020: 50 · 2019: 32 · 2018: 57 · 2017: 56 · 2016: 35 · 2015: 31
FWCI
43.43
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Canadian Institutes of Health Research
  • National Heart, Lung, and Blood Institute (UM1HL117922, UM1HL088939, UM1HL088955, U01HL088942)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords
atrial fibrillation, surgical ablation, mitral valve surgery, pulmonary vein isolation, left atrial appendage closure, persistent atrial fibrillation, long-standing persistent atrial fibrillation, permanent pacemaker implantation, mortality, stroke risk
MeSH terms
Aged, Atrial Fibrillation, Cardiovascular Diseases, Female, Heart Valve Diseases, Humans, Male, Middle Aged, Mitral Valve, Postoperative Complications, Quality of Life, Electrocardiography, Ambulatory, Catheter Ablation, Heart Valve Prosthesis Implantation, Kaplan-Meier Estimate, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review